Investors

Press Releases

Jun 16, 2022
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
Keep Reading
Jun 07, 2022
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
Keep Reading
Jun 02, 2022
Twist Bioscience to Present at Upcoming Investor Conferences
Keep Reading
May 31, 2022
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
Keep Reading
May 18, 2022
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
Keep Reading
May 10, 2022
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
Keep Reading
May 09, 2022
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
Keep Reading
May 05, 2022
Twist Bioscience Reports Second Quarter 2022 Financial Results
Keep Reading
May 02, 2022
Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022
Keep Reading
Apr 28, 2022
Twist Bioscience Launches High Throughput Antibody Production Platform
Keep Reading